Krystal Biotech, Inc.
KRYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $89 | $11 | -$140 | -$70 |
| Dep. & Amort. | $7 | $5 | $4 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $49 | $40 | $33 | $15 |
| Change in WC | -$14 | -$38 | $3 | $2 |
| Other Non-Cash | -$7 | -$107 | -$1 | $1 |
| Operating Cash Flow | $123 | -$89 | -$101 | -$48 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$12 | -$53 | -$68 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$458 | -$509 | -$319 | -$190 |
| Inv. Sales/Matur. | $299 | $503 | $258 | $32 |
| Other Inv. Act. | $0 | $100 | $0 | $0 |
| Investing Cash Flow | -$163 | $83 | -$114 | -$227 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $32 | $203 | $36 | $356 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | -$1 | -$1 | -$8 |
| Financing Cash Flow | $27 | $203 | $35 | $348 |
| Forex Effect | -$0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | -$13 | $196 | -$179 | $73 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $358 | $162 | $341 | $268 |
| End Cash | $345 | $358 | $162 | $341 |
| Free Cash Flow | $119 | -$101 | -$154 | -$116 |